CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03394027
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:01.362008+00:00
- Published At
- 2022-01-12T00:00:00+00:00
- Record Updated At
- 2022-08-23
- Results Posted At
- 2022-01-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Triple Negative Breast Cancer", "Endometrial Cancer", "Hormone Receptor Positive, HER2 Negative Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-08-23"- protocolSection.identificationModule.nctId
"NCT03394027"- protocolSection.identificationModule.officialTitle
"A Phase 2 Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-01-12"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.